Arthritis drug shown to reduce risk of COVID death in large U.K. trial

over 3 years in torontosun

Eli Lilly and Incyte’s arthritis drug baricitinib helped reduce the risk of death in hospitalized COVID-19 patients by 13% regardless of which other coronavirus treatment they were given, according to a large British study. Over 8,000 patients were administered baricitinib in addition to usual care, at random, or usual care alone, as part of the […]

Mentioned in this news
Share it on